{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:50:39Z","timestamp":1786373439100,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.2215\/cjn.02850315","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:30:15Z","timestamp":1445301015000},"page":"2159-2169","source":"Crossref","is-referenced-by-count":57,"title":["BP and Renal Outcomes in Diabetic Kidney Disease"],"prefix":"10.2215","volume":"10","author":[{"given":"David J.","family":"Leehey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas V.","family":"Emanuele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Whaley-Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Palevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda F.","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20230601","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1016\/j.amjmed.2003.10.018","article-title":"The importance of blood pressure control in the patient with diabetes.","volume":"116","author":"Bakris","year":"2004","journal-title":"Am J Med"},{"key":"R3-10-20230601","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.285.6343.685","article-title":"Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.","volume":"285","author":"Mogensen","year":"1982","journal-title":"Br Med J (Clin Res Ed"},{"key":"R4-10-20230601","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(83)92462-5","article-title":"Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.","volume":"1","author":"Parving","year":"1983","journal-title":"Lancet"},{"key":"R5-10-20230601","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bmj.293.6545.471","article-title":"Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.","volume":"293","author":"Bj\u00f6rck","year":"1986","journal-title":"Br Med J (Clin Res Ed"},{"key":"R6-10-20230601","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/bmj.294.6585.1443","article-title":"Effect of antihypertensive treatment on kidney function in diabetic nephropathy.","volume":"294","author":"Parving","year":"1987","journal-title":"Br Med J (Clin Res Ed"},{"key":"R7-10-20230601","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bmj.297.6656.1086","article-title":"Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.","volume":"297","author":"Parving","year":"1988","journal-title":"BMJ"},{"key":"R8-10-20230601","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/1056-8727(95)80030-I","article-title":"Effects of intensification of antihypertensive care in diabetic nephropathy.","volume":"9","author":"Sawicki","year":"1995","journal-title":"J Diabetes Complications"},{"key":"R9-10-20230601","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/00004872-199917100-00019","article-title":"Effects of intensified antihypertensive treatment in diabetic nephropathy: Mortality and morbidity results of a prospective controlled 10-year study.","volume":"17","author":"Trocha","year":"1999","journal-title":"J Hypertens"},{"key":"R10-10-20230601","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0272-6386(99)70036-3","article-title":"Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy.","volume":"34","author":"Lewis","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R11-10-20230601","first-page":"B54","article-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.","volume":"23","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"key":"R12-10-20230601","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1523-1755.2003.00885.x","article-title":"The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study.","volume":"63","author":"Keane","year":"2003","journal-title":"Kidney Int"},{"key":"R13-10-20230601","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","article-title":"Effects of blood pressure level on progression of diabetic nephropathy: Results from the RENAAL study.","volume":"163","author":"Bakris","year":"2003","journal-title":"Arch Intern Med"},{"key":"R14-10-20230601","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1681\/ASN.2004110919","article-title":"Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical implications and limitations.","volume":"16","author":"Pohl","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R15-10-20230601","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","article-title":"Preserving renal function in adults with hypertension and diabetes: A consensus approach.","volume":"36","author":"Bakris","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R16-10-20230601","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R18-10-20230601","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"R19-10-20230601","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8).","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"R20-10-20230601","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy.","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"R22-10-20230601","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/10641960802068477","article-title":"Ambulatory blood pressure variability is increased in diabetic hypertensives.","volume":"30","author":"Ozawa","year":"2008","journal-title":"Clin Exp Hypertens"},{"key":"R23-10-20230601","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus.","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"R24-10-20230601","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial.","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"R25-10-20230601","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease.","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"R26-10-20230601","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): Multicentre, randomised controlled trial.","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"R27-10-20230601","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1523-1755.2002.00213.x","article-title":"Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.","volume":"61","author":"Schrier","year":"2002","journal-title":"Kidney Int"},{"key":"R28-10-20230601","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2369-6-8","article-title":"Progression of kidney disease in type 2 diabetes - beyond blood pressure control: An observational study.","volume":"6","author":"Leehey","year":"2005","journal-title":"BMC Nephrol"},{"key":"R29-10-20230601","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: A systematic review and meta-analysis.","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"R30-10-20230601","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinternmed.2011.619","article-title":"Blood pressure components and end-stage renal disease in persons with chronic kidney disease: The Kidney Early Evaluation Program (KEEP).","volume":"172","author":"Peralta","year":"2012","journal-title":"Arch Intern Med"},{"key":"R32-10-20230601","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD.","volume":"62","author":"Taler","year":"2013","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201512000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:53Z","timestamp":1786369553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201512000-00010"}},"subtitle":["The Veterans Affairs Nephropathy in Diabetes Trial"],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.02850315","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}